Event Detail (Archived)

Development of Therapies Selectively Targeting Cancer Stem Cells

  • This event already took place in May 2012
  • 116 Rockefeller Research Laboratories, MSKCC, 430 E. 67th St.

Event Details

Type
Other Tri-Institutional Events
Speaker(s)
Malcolm Moore, D.Phil., member and lab head, cell biology program, Memorial Sloan-Kettering Cancer Center
Open to
Public
Reception
Refreshments, 4:15 p.m.
Contact
Gregory Erskine
Phone
(212) 639-2220
Sponsor
Gregory Erskine
(212) 639-2220
erskineg@mskcc.org

Related News

The value of publishing negative data

Scientific publishing has a bias against negative results and that hurts science, says Tim Fessenden, editor of Life Science Alliance, a publication of Rockefeller University Press. Here’s how journal editors can help.

Researchers identify gene that calms the mind and improves attention in mice

Study demonstrates that the Homer1 gene improves focus by reducing "noise" in the prefrontal cortex, with implications for the study of ADHD and other attention disorders.

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

Related Events

Pre-Seminar Coffee and Cookies

| LOWER LEVEL GREENBERG BUILDING (CRC)

Chemical Biology Approaches to Define Immunomodulatory Protease Functions

| 116 ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)